Genenta Science Spa Stock Buy Hold or Sell Recommendation
| GNTA Stock | USD 4.78 0.01 0.21% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Genenta Science SpA is 'Strong Sell'. Macroaxis provides Genenta Science buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding GNTA positions.
Check out Genenta Science Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Genenta and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Genenta Science SpA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Genenta |
Execute Genenta Science Buy or Sell Advice
The Genenta recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Genenta Science SpA. Macroaxis does not own or have any residual interests in Genenta Science SpA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Genenta Science's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Moderately volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Genenta Science Trading Alerts and Improvement Suggestions
| Genenta Science SpA had very high historical volatility over the last 90 days | |
| Genenta Science SpA has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (11.65 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Genenta Science SpA currently holds about 37.24 M in cash with (11.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.04. | |
| Genenta Science SpA has a frail financial position based on the latest SEC disclosures | |
| Roughly 39.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Genenta Science Shares Down 4.9 percent - Whats Next - MarketBeat |
Genenta Science Returns Distribution Density
The distribution of Genenta Science's historical returns is an attempt to chart the uncertainty of Genenta Science's future price movements. The chart of the probability distribution of Genenta Science daily returns describes the distribution of returns around its average expected value. We use Genenta Science SpA price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Genenta Science returns is essential to provide solid investment advice for Genenta Science.
| Mean Return | 0.44 | Value At Risk | -9.87 | Potential Upside | 11.19 | Standard Deviation | 6.56 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Genenta Science historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Genenta Stock Institutional Investors
| Shares | Alti Global Inc | 2024-06-30 | 200.3 K | Algebris Investment Management (uk) Llp | 2024-09-30 | 45 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1000 | Ubs Group Ag | 2024-06-30 | 893 | Bank Julius Baer & Co. Ltd, Zurich | 2024-06-30 | 0.0 |
Genenta Science Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Genenta Science or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Genenta Science's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Genenta stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.34 | |
β | Beta against Dow Jones | 0.79 | |
σ | Overall volatility | 6.72 | |
Ir | Information ratio | 0.05 |
Genenta Science Volatility Alert
Genenta Science SpA is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Genenta Science's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Genenta Science's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Genenta Science Fundamentals Vs Peers
Comparing Genenta Science's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Genenta Science's direct or indirect competition across all of the common fundamentals between Genenta Science and the related equities. This way, we can detect undervalued stocks with similar characteristics as Genenta Science or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Genenta Science's fundamental indicators could also be used in its relative valuation, which is a method of valuing Genenta Science by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Genenta Science to competition |
| Fundamentals | Genenta Science | Peer Average |
| Return On Equity | -0.43 | -0.31 |
| Return On Asset | -0.26 | -0.14 |
| Current Valuation | 69.89 M | 16.62 B |
| Shares Outstanding | 18.29 M | 571.82 M |
| Shares Owned By Insiders | 38.68 % | 10.09 % |
| Shares Owned By Institutions | 7.77 % | 39.21 % |
| Number Of Shares Shorted | 5.26 K | 4.71 M |
| Price To Book | 4.97 X | 9.51 X |
| EBITDA | (11.69 M) | 3.9 B |
| Net Income | (11.65 M) | 570.98 M |
| Cash And Equivalents | 37.24 M | 2.7 B |
| Cash Per Share | 2.04 X | 5.01 X |
| Total Debt | 14 | 5.32 B |
| Current Ratio | 34.15 X | 2.16 X |
| Book Value Per Share | 0.92 X | 1.93 K |
| Cash Flow From Operations | (11.21 M) | 971.22 M |
| Short Ratio | 0.20 X | 4.00 X |
| Earnings Per Share | (0.51) X | 3.12 X |
| Target Price | 20.8 | |
| Number Of Employees | 14 | 18.84 K |
| Beta | 0.74 | -0.15 |
| Market Capitalization | 87.61 M | 19.03 B |
| Total Asset | 22.35 M | 29.47 B |
| Retained Earnings | (47.14 M) | 9.33 B |
| Working Capital | 19.52 M | 1.48 B |
| Net Asset | 22.35 M |
Note: Disposition of 64562 shares by Rosenwald Lindsay A Md of Genenta Science subject to Rule 16b-3 [view details]
Genenta Science Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Genenta . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 181.84 | |||
| Daily Balance Of Power | (0.05) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 4.8 | |||
| Day Typical Price | 4.79 | |||
| Price Action Indicator | (0.02) | |||
| Period Momentum Indicator | (0.01) |
About Genenta Science Buy or Sell Advice
When is the right time to buy or sell Genenta Science SpA? Buying financial instruments such as Genenta Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Genenta Science in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Shipbuilding Railroad Equipment Thematic Idea Now
Shipbuilding Railroad Equipment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Shipbuilding Railroad Equipment theme has 16 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Shipbuilding Railroad Equipment Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Genenta Science Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genenta Science. If investors know Genenta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genenta Science listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.51) | Return On Assets (0.26) | Return On Equity (0.43) |
The market value of Genenta Science SpA is measured differently than its book value, which is the value of Genenta that is recorded on the company's balance sheet. Investors also form their own opinion of Genenta Science's value that differs from its market value or its book value, called intrinsic value, which is Genenta Science's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genenta Science's market value can be influenced by many factors that don't directly affect Genenta Science's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genenta Science's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genenta Science is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genenta Science's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.